Dr. Jamal Misleh, MD
Claim this profileMedical Oncology Hematology Consultants, PA
Expert in Breast Cancer
Studies Pancreatic Cancer
28 reported clinical trials
48 drugs studied
About Jamal Misleh, MD
Education:
- Obtained MD from the University of Miami School of Medicine in 2003.
Experience:
- Completed an Internal Medicine Internship (2003-2004) and Residency (2004-2006) at the Hospital of the University of Pennsylvania.
- Undertook a Fellowship in Hematology/Medical Oncology at the University of Maryland Medical Center (2006-2009).
- Board Certified in Hematology and Medical Oncology by the American Board of Internal Medicine since 2009.
- Affiliated with Medical Oncology Hematology Consultants, PA, and serves as the Director of US Oncology Network Clinical Trials.
Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2
2Pancreatic Cancer
Stage IV
NRG1 positive
Stage III
Affiliated Hospitals
Clinical Trials Jamal Misleh, MD is currently running
Genomic Testing
for Breast Cancer
The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study arms at low incremental effort and cost. FLEX Registry will utilize an adaptive design, where additional targeted substudies and arms can be added after the initial study is opened.
Recruiting1 award N/A3 criteria
Radium-223 + Docetaxel
for Prostate Cancer
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Recruiting2 awards Phase 323 criteria
More about Jamal Misleh, MD
Clinical Trial Related3 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Jamal Misleh, MD has experience with
- Pembrolizumab
- Abemaciclib
- Placebo
- LOXO-305
- Rituximab
- Botensilimab
Breakdown of trials Jamal Misleh, MD has run
Breast Cancer
Pancreatic Cancer
Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jamal Misleh, MD specialize in?
Jamal Misleh, MD focuses on Breast Cancer and Pancreatic Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jamal Misleh, MD currently recruiting for clinical trials?
Yes, Jamal Misleh, MD is currently recruiting for 6 clinical trials in Newark Delaware. If you're interested in participating, you should apply.
Are there any treatments that Jamal Misleh, MD has studied deeply?
Yes, Jamal Misleh, MD has studied treatments such as Pembrolizumab, Abemaciclib, Placebo.
What is the best way to schedule an appointment with Jamal Misleh, MD?
Apply for one of the trials that Jamal Misleh, MD is conducting.
What is the office address of Jamal Misleh, MD?
The office of Jamal Misleh, MD is located at: Medical Oncology Hematology Consultants, PA, Newark, Delaware 19713 United States. This is the address for their practice at the Medical Oncology Hematology Consultants, PA.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.